Table 1. Clinical characteristics of patients by 3′UTR assessment set.
| Training set | Validation set | |||||||
|---|---|---|---|---|---|---|---|---|
| Number of patients | Low risk(%) | High risk(%) | p-value | Number of patients | Low risk(%) | High risk(%) | p-value | |
| Age | 0.88 | 0.84 | ||||||
| >50 years | 84 | 69 (82.1) | 15 (17.9) | 86 | 67 (77.9) | 19 (22.1) | ||
| ≤50 years | 80 | 65 (81.3) | 15 (18.8) | 77 | 61 (79.2) | 16 (20.8) | ||
| Lymph node status | 0.70 | 0.21 | ||||||
| negative | 130 | 107 (82.3) | 23 (17.7) | 129 | 104 (80.6) | 25 (19.4) | ||
| positive | 34 | 27 (79.4) | 7 (20.6) | 34 | 24 (70.6) | 10 (29.4) | ||
| Tumor size | 0.48 | 0.43 | ||||||
| ≤2 cm | 41 | 35 (85.4) | 6 (14.6) | 41 | 34 (82.9) | 7 (17.1) | ||
| >2 cm | 123 | 99 (80.5) | 24 (19.5) | 122 | 94 (77.0) | 28 (23.0) | ||